Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made of the patient experience of people with diabetes.
Answered by Jane Ellison
NHS England surveys capture the experiences of people with a wide range of conditions including diabetes but, with the exception of the cancer patient experience survey, they are not condition specific. As part of a forthcoming review of patient experience surveys, NHS England will consider whether it is best to collect information as it does currently or by specific conditions.
Professor Jonathan Valabhji, the National Clinical Director, has reported that last year’s Patient Experience of Diabetes Services pilot survey, which collected information from people with diabetes about their care, received very positive feedback.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people in England currently hold a medical exemption certificate.
Answered by George Freeman
As of 31 January 2015 the number of people in England who hold a valid medical exemption certificate is 1,769,872. This is based on the number of certificates issued by the NHS Business Services Authority within the previous five years.
No estimate has been made of the number of people in England who meet the underlying eligibility criteria for a medical exemption certificate.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate he has made of the number of people in England who are eligible for a medical exemption certificate.
Answered by George Freeman
As of 31 January 2015 the number of people in England who hold a valid medical exemption certificate is 1,769,872. This is based on the number of certificates issued by the NHS Business Services Authority within the previous five years.
No estimate has been made of the number of people in England who meet the underlying eligibility criteria for a medical exemption certificate.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, whether patient uptake of insulin pumps has reached the levels set by the NICE technology appraisal 151 benchmarking tool issued in July 2008; how many people have taken up the use of such pumps; and if he will make a statement.
Answered by George Freeman
Commissioners and providers should make insulin pumps available for those people with Type 1 diabetes who meet the criteria in the National Institute for Health and Care Excellence’s technology appraisal guidance on continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151) as well as ensuring that relevant structured patient education is provided to support people newly diagnosed with diabetes and at appropriate points in their life as their condition progresses.
Information on the number of people using insulin pumps is not collected centrally.
The United Kingdom Insulin Pump Audit, published in May 2013, collected data from across the United Kingdom. The audit demonstrated that 6% of adults with Type 1 diabetes and 19% of children with Type 1 diabetes were being treated with insulin pumps. The audit’s findings are available at:
www.diabetes.org.uk/Documents/News/The_United_Kingdom_Insulin_Pump_Audit_May_2013.pdf
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 3 December 2014 to Question 216036, if he will place in the Library data tables from the Care Quality Commission's bespoke analyses, referred to in its report Thematic data review of diabetes care pathways, published on 16 October 2014, broken down by (a) commissioner and (b) provider.
Answered by Jane Ellison
The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England.
A copy of the information requested has been attached.
The CQC has advised that the attached dataset contains the breakdown (at National Health Service acute provider and clinical commissioning group (CCG) level) of bespoke analysis carried out by the CQC as part of the 'Thematic data review of diabetes care pathways: secondary care analysis comparing people with and without diabetes' that was published alongside the CQC's 2013/14 State of Care report on 16 October 2014.
The analysis compares the outcomes within each provider or CCG for people with diabetes against a reference group of similar people without diabetes. It is not a comparison of performance between providers or CCGs and it would be inappropriate to use the data in this way. The analysis at provider and CCG level should be treated as experimental and the measures should not be considered as judgements of providers or CCGs.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Home Office:
To ask the Secretary of State for the Home Department, with reference to the Answer of 28 March 2011 to Question 45398, whether it remains the policy of her Department that a ban on the testing of household products on animals will apply to both finished products and ingredients; whether there is now a definition of household products; and when the ban will be implemented.
Answered by Baroness Featherstone
We have made a commitment to ban the testing of household products on animals. Although superficially straightforward, this issue has not been easy to resolve. The key issue is around ingredients. We are currently engaging with
stakeholders to develop a solution that is workable, but does not have a chain of unforeseen circumstances.
Any solution has to be legally viable since we cannot ban testing which may be required under UK or EU law. The solution we develop must not preclude research that is a lawful requirement nor that which has significant benefits to people, the environment or animals. Nor should it drive research overseas.
There is, at present, no authoritative definition of household products in the United Kingdom or European legislation. Through stakeholder engagement we are seeking to develop an agreed definition.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how many animals were used for testing (a) finished household products and (b) household product ingredients in each of the last five years.
Answered by Baroness Featherstone
The Home Office does not collect data on the number of animals used in scientific procedures for testing (a) finished household products or (b) household product ingredients. It does however collect data on the number of
animals used in procedures undertaken for the testing of substances used in the household, in Great Britain.
In 2010 there were 24 animals used in procedures for the testing of substances used in the household. In 2009, 2011, 2012 and 2013 there were no animals used in procedures for the testing of substances used in the household.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 25 November 2014 to Question 215005, if he will place in the Library the detailed data tables underpinning the bespoke analyses conducted by the Care Quality Commission, referred to in its report Thematic data review of diabetes care pathways, published on 16 October 2014.
Answered by Jane Ellison
The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England. The CQC has provided the following information.
A copy of the information requested has been attached.
The report ‘The State of health and adult social care in England 2013/14 – Technical annex: Thematic data review of diabetes care pathways’ was published on the CQC’s website on 16 October.
The CQC undertook two separate pieces of bespoke analysis, which were summarised in the 13/14 State of Care (technical annex): Thematic Data Review of Diabetes Care Pathways. Neither of these documents were published on the CQC’s website. Drafts of both have been previously circulated to the CQC’s external advisory group. These two separate pieces of analysis have been attached to this response.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many hospital admissions for (a) hypoglycaemia and (b) diabetic ketoacidosis there were in each local commissioning area of people aged (i) 17 and under, (ii) between 17 and 65 and (iii) 65 and over in each of the last 10 years.
Answered by Jane Ellison
The attached table shows finished admission episodes (FAEs) with a primary diagnosis of hypoglycaemia and diabetic ketoacidosis by primary care trust (PCT) of residence for ages (i) 0 to 17, (ii) 18 to 64 and (iii) 65 and over from 2003-04 to 2012-13. PCT of residence has been used as this data is available for the 10 year period requested.
The data we have provided should not be considered a count of people as the same person may have been admitted on more than one occasion.
Reference should be made to the footnotes when interpreting the data.
Asked by: Adrian Sanders (Liberal Democrat - Torbay)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the contribution of the Parliamentary Under-Secretary of State for Health of 18 June 2014, Official Report, column 11WH, on Melbourne Declaration on diabetes, when NHS England plans to roll out the diabetes patient experience survey across all NHS services in England.
Answered by Jane Ellison
The Patient Experience of Diabetes Services survey is commissioned by the Healthcare Quality Improvement Partnership, on behalf of NHS England, and delivered by the Health and Social Care Information Centre, working in collaboration with Diabetes UK and Public Health England (PHE). It will therefore be a matter for PHE and NHS England to decide on future plans for this survey.
There has been no decision made about the future of the Patient Experience of Diabetes Survey. NHS England is currently reviewing the whole National Clinical Audit and Patient Outcomes Programme collectively, including the pilots that have reported. The first of these meetings was on 11 November.
My Rt. hon. Friend, The Secretary of State meets with NHS England on a weekly basis and discusses a wide range of healthcare issues.
However, there have been no specific discussions between the Secretary of State for Health and NHS England on the future funding of the Patient Experience of Diabetes Survey or between Ministers and officials of the Department and NHS England on plans to roll out the diabetes patient experience survey across all NHS services in England.